Aimmune Therapeutics, Inc. (AIMT) has 86 open-market insider trades by 21 insiders since 2015. The most active filer is Mary M. Rozenman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Societe des Produits Nestle S.A. | 10% Owner | — | 1 | $3.4B | 2020-10-13 |
| NIMCO US, Inc. | 10% Owner | — | 1 | $226.0M | 2018-11-28 |
| Nestle SA | 10% Owner | — | 1 | $32.0M | 2020-04-22 |
| Stephen George Dilly | CEOPres | — | 12 | $26.5M | 2018-06-11 |
| Susan E. Barrowcliffe | — | — | 10 | $9.2M | 2018-11-19 |
| Patrick G. Enright | Dir | — | 4 | $8.3M | 2020-10-13 |
| Mary M. Rozenman | — | — | 13 | $7.1M | 2019-03-01 |
| Foresite Capital Fund II, L.P. | 10% | — | 2 | $5.8M | 2015-08-24 |
| Longitude Capital Partners II, LLC | 10% | — | 1 | $5.0M | 2015-08-11 |
| Douglas T. Sheehy | — | — | 13 | $4.2M | 2020-10-13 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Societe des Produits Nestle S.A. | 10% Owner | Buy | $3.4B | 2020-10-13 |
| Patrick G. Enright | Director | Buy | $1.7M | 2020-03-17 |
| Andrew Oxtoby | Chief Commercial Officer | Buy | $44K | 2020-03-13 |
| Eric Bjerkholt | CFO | Buy | $15K | 2020-03-12 |
| Jayson Donald Alexander Dallas | President | Buy | $50K | 2020-03-10 |
| Eric Bjerkholt | CFO | Buy | $19K |
Companies that share insiders with AIMT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2020-03-09 |
| Nestle SA | 10% Owner | Buy | $32.0M | 2020-02-07 |
| Douglas T. Sheehy | — | Sell | $15K | 2020-01-16 |
| Daniel C. Adelman M.D. | — | Sell | $700K | 2020-01-02 |
| Douglas T. Sheehy | — | Sell | $330K | 2019-12-26 |
| Daniel C. Adelman M.D. | — | Sell | $601K | 2019-12-09 |
| Eric Bjerkholt | CFO | Buy | $35K | 2019-09-18 |
| Jayson Donald Alexander Dallas | CEO & President | Buy | $101K | 2018-11-19 |
| Susan E. Barrowcliffe | — | Sell | $1.2M | 2018-11-19 |
| Eric Bjerkholt | CFO | Buy | $49K | 2018-06-13 |